Back to Search Start Over

High Dose of A Conjugated Linoleic Acid Mixture Increases Insulin Resistance in Rats Fed Either A Low Fat or A High Fat Diet.

Authors :
Bezan PN
Holland H
de Castro GS
Cardoso JFR
Ovidio PP
Calder PC
Jordao AA
Source :
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association [Exp Clin Endocrinol Diabetes] 2018 Jun; Vol. 126 (6), pp. 379-386. Date of Electronic Publication: 2018 Jan 31.
Publication Year :
2018

Abstract

Obesity and related diseases are becoming more prevalent. Conjugated linoleic acid (CLA) might be a useful coadjutant treatment helping to decrease fat mass. However, the precise impact of CLA is unclear because the decreased body fat mass is followed by an increase in insulin resistance. This study aimed to evaluate some of the consequences of a high dose of CLA in rats fed a normal low fat or a high fat diet for 30 days. Male Wistar rats were separated into 4 groups (each n = 10): Control group receiving 7% fat (soybean oil); CLA group receiving 4% soybean oil and 3% CLA mixture; animal fat (AF) group, receiving 45% fat (lard); and animal fat plus CLA (AF+CLA) group, receiving 42% lard and 3% CLA mixture. The CLA mixture contained 39.32 mole% c9,t11-CLA and 40.50 mole% t10,c12-CLA. After 30 days, both CLA groups (CLA and AF+CLA groups) developed insulin resistance, with an increase in glucose in the fasting state and in an insulin tolerance test. The CLA group had increased liver weight and percentage of saturated fatty acids in liver and adipose tissue. Feeding the high fat diet resulted in increased hepatic triacylglycerol accumulation and this was exacerbated by dietary CLA. It is concluded that a high dose of CLA mixture increases insulin resistance and exacerbates hepatic steatosis when combined with a high fat diet.<br />Competing Interests: The authors declare no conflict of interests. PN Bezan, H Holland and GS de Castro were supported by São Paulo Research Foundation – FAPESP, Brazil (11/07846-7, 11/07845-0 and 10/00408-1). PCC is an advisor to Pronova BioPharma, Danone Nutricia Research, DSM, Cargill, Smartfish, Sancilio and Solutex.<br /> (© Georg Thieme Verlag KG Stuttgart · New York.)

Details

Language :
English
ISSN :
1439-3646
Volume :
126
Issue :
6
Database :
MEDLINE
Journal :
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Publication Type :
Academic Journal
Accession number :
29388176
Full Text :
https://doi.org/10.1055/s-0043-118348